VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,358,285 | -18.1% | 87,636 | -8.4% | 0.14% | -40.7% |
| Q2 2023 | $2,880,473 | +98.7% | 95,665 | +113.4% | 0.24% | +92.9% |
| Q1 2023 | $1,449,992 | +534.6% | 44,822 | +462.2% | 0.13% | +472.7% |
| Q4 2022 | $228,506 | -4.0% | 7,973 | +28.6% | 0.02% | -15.4% |
| Q1 2022 | $238,000 | -20.1% | 6,199 | -38.7% | 0.03% | -29.7% |
| Q3 2021 | $298,000 | -50.6% | 10,109 | -43.0% | 0.04% | -51.9% |
| Q2 2021 | $603,000 | +42.6% | 17,738 | +36.3% | 0.08% | +24.2% |
| Q1 2021 | $423,000 | -10.8% | 13,013 | -1.2% | 0.06% | -17.3% |
| Q4 2020 | $474,000 | +131.2% | 13,174 | +150.9% | 0.08% | +50.0% |
| Q3 2020 | $205,000 | -56.7% | 5,250 | +183.8% | 0.05% | +163.2% |
| Q2 2019 | $473,000 | – | 1,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |